Th1 and Th17 immunocompetence in humanized NOD/SCID/IL2rgammanull mice.
Rajesh
Deepika
D
Department of Surgery, Transplant Division, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792, USA.
Zhou
Ying
Y
Jankowska-Gan
Ewa
E
Roenneburg
Drew Allan
DA
Dart
Melanie L
ML
Torrealba
Jose
J
Burlingham
William J
WJ
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D015703:Antigens, CD / Q000096:biosynthesis; D002478:Cells, Cultured; D024062:Collagen Type V / Q000276:immunology / Q000378:metabolism; D004195:Disease Models, Animal; D004622:Embryo, Mammalian; D005240:Feasibility Studies; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology*; D007121:Immunocompetence / Q000187:drug effects; D007371:Interferon-gamma / Q000276:immunology / Q000378:metabolism; D020381:Interleukin-17 / Q000276:immunology / Q000378:metabolism*; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D009504:Neutrophils / Q000276:immunology; D015375:Receptors, Interleukin-2 / Q000235:genetics; D013745:Tetanus Toxoid / Q000276:immunology / Q000378:metabolism; D018417:Th1 Cells / Q000187:drug effects / Q000276:immunology / Q000378:metabolism* / Q000473:pathology
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D024062:Collagen Type V; D020381:Interleukin-17; D015375:Receptors, Interleukin-2; D013745:Tetanus Toxoid; D007371:Interferon-gamma